548 related articles for article (PubMed ID: 7683375)
1. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Cho H; Katzenellenbogen BS
Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
[TBL] [Abstract][Full Text] [Related]
2. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence.
Fujimoto N; Katzenellenbogen BS
Mol Endocrinol; 1994 Mar; 8(3):296-304. PubMed ID: 7517003
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
Aronica SM; Katzenellenbogen BS
Mol Endocrinol; 1993 Jun; 7(6):743-52. PubMed ID: 7689695
[TBL] [Abstract][Full Text] [Related]
4. Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3',5'-monophosphate and ligands including antiestrogens.
Ince BA; Montano MM; Katzenellenbogen BS
Mol Endocrinol; 1994 Oct; 8(10):1397-406. PubMed ID: 7531820
[TBL] [Abstract][Full Text] [Related]
5. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
6. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.
Ignar-Trowbridge DM; Pimentel M; Parker MG; McLachlan JA; Korach KS
Endocrinology; 1996 May; 137(5):1735-44. PubMed ID: 8612509
[TBL] [Abstract][Full Text] [Related]
7. Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters.
Kraus WL; Montano MM; Katzenellenbogen BS
Mol Endocrinol; 1993 Dec; 7(12):1603-16. PubMed ID: 8145766
[TBL] [Abstract][Full Text] [Related]
8. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
Bollig A; Miksicek RJ
Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines.
Cho HS; NG PA; Katzenellenbogen BS
Mol Endocrinol; 1991 Sep; 5(9):1323-30. PubMed ID: 1722871
[TBL] [Abstract][Full Text] [Related]
10. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
11. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity.
Le Goff P; Montano MM; Schodin DJ; Katzenellenbogen BS
J Biol Chem; 1994 Feb; 269(6):4458-66. PubMed ID: 8308015
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells.
Hurd C; Dinda S; Khattree N; Moudgil VK
Oncogene; 1999 Jan; 18(4):1067-72. PubMed ID: 10023683
[TBL] [Abstract][Full Text] [Related]
14. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.
Cho H; Aronica SM; Katzenellenbogen BS
Endocrinology; 1994 Feb; 134(2):658-64. PubMed ID: 7507831
[TBL] [Abstract][Full Text] [Related]
15. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
16. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
McInerney EM; Ince BA; Shapiro DJ; Katzenellenbogen BS
Mol Endocrinol; 1996 Dec; 10(12):1519-26. PubMed ID: 8961262
[TBL] [Abstract][Full Text] [Related]
17. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.
Ignar-Trowbridge DM; Teng CT; Ross KA; Parker MG; Korach KS; McLachlan JA
Mol Endocrinol; 1993 Aug; 7(8):992-8. PubMed ID: 8232319
[TBL] [Abstract][Full Text] [Related]
18. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells.
Krishnan V; Wang X; Safe S
J Biol Chem; 1994 Jun; 269(22):15912-7. PubMed ID: 8195246
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
Duan R; Porter W; Safe S
Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
